Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S.
about
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patientsAntibiotic lock for the prevention of catheter-related infection in neonatesAntibiotic lock for the prevention of catheter-related sepsis in neonatesProphylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patientsCatheter impregnation, coating or bonding for reducing central venous catheter related infections in adultsProphylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous cathetersProphylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous cathetersProphylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patientsMultiple versus single lumen umbilical venous catheters for newborn infantsMultiple versus single lumen umbilical venous catheters for newborn infantsLysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfacesIn-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trialIncidence of and factors associated with catheter-related bloodstream infection in patients with advanced solid tumors on home parenteral nutrition managed using a standardized catheter care protocolThe impact of statistical choices on neonatal intensive care unit quality ratings based on nosocomial infection rates.Establishing a pediatric cardiac intensive care unit - Special considerations in a limited resources environment.Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital.The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades.Replacement of administration sets (including transducers) for peripheral arterial catheters: a systematic review.Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit.Formulation, stability, and administration of parenteral nutrition with new lipid emulsions.Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach.Catheter-related bloodstream infections in neonatal intensive care units.Consensus recommendations for use of central venous access devices in haemophilia.Effect of 4 % chlorhexidine on cord colonization among hospital and community births in India: a randomized controlled study.Central venous access devices in patients with hemophilia.Vascular access for home intravenous therapy in children.Central and peripheral venous lines-associated blood stream infections in the critically ill surgical patients.How to deal with dialysis catheters in the ICU setting.Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation.Chlorhexidine: expanding the armamentarium for infection control and prevention.Prospective pilot study on the incidence of infections caused by peripheral venous catheters at a general surgical ward.Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonatesPeriprosthetic knee infection: ten strategies that work.The evaluation and management of postnatal thromboses.Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative.Is there still a role for peripheral parenteral nutrition?Infection in pediatric interventional radiology.Healthcare-associated infection prevention in pediatric intensive care units: a review.Catheter-related infections in pediatric patients with cancer.Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations.
P2860
Q21261533-8DBFAFBB-6CF4-40A4-9A5D-A9AA4933014BQ24187276-2EB344A6-286F-40B2-BB3F-39BAA992CD8CQ24202017-B2DE9325-A75C-41D3-BCA8-FECF63D00BFFQ24202372-52DE92D0-AA7E-4165-A05D-63272C8FDF7EQ24240499-3FD5457B-81D9-4859-91BC-264B9BD89D53Q24242582-2AA40711-2CE1-4F96-AB57-5A49E9ABDB4EQ24244417-3DE23BF4-47DB-4411-934C-FC4939D3651AQ24246346-16184079-292B-49EC-B0A6-D98FC43A37E5Q24246663-8833D6C8-F3A6-40F7-9041-90EE0FD0E4DFQ24248132-074EB9EA-FB32-4F31-A61E-5463EFAC017CQ24650674-89BF1AF5-F899-4037-94FC-CA95835E9FF9Q28384386-B4CFAC2E-CF76-4DC3-9731-5B96AD61CFC8Q33743672-347D1052-B567-4218-9AFE-C6E1173CB597Q33923319-E2AEF917-EB6F-4111-A14C-BA72E3CD5350Q34065315-0B9DDE29-35F6-436A-9069-5B127A32EB11Q34221581-FD77C980-48E5-46D0-B7B7-5804F33AD7A3Q34381653-63BA4737-0E44-4068-8A33-146143364113Q34508627-5E977A25-857B-4421-8279-E50C5198FBCEQ34762432-9AC2CB9C-A49B-4756-A44F-87C1E815671FQ35008571-3E2958B4-6197-4CE8-8828-EB7D8259E9B2Q35642641-2EE2DBE6-0E35-4CDF-8985-11A02A8ECF75Q35649262-1005CCFA-E6D0-4B00-B01F-23F633A86C3DQ35882783-075E28E4-A5DE-47B5-951E-B03F696057C2Q36092691-F9FFE4BE-711D-4ECA-B6A6-B26006642686Q36315174-78E4A4FE-E2EF-4C36-A2FA-4B33E6581B21Q36357952-F2CB5010-D44A-4930-9A1B-132420CFFD6EQ36367467-B71A0597-6A19-4F4B-9644-FFA91F49136BQ36478648-63000A65-8A8B-4D47-B39E-15CA85BDF814Q36593530-7C0E1CDC-DEDB-4701-BA1D-BCBE02CB8CD1Q37048690-D6337A78-EAE0-4438-A8A5-4B8D1B798C7AQ37103075-97EA625F-B9D8-44F8-9AA8-08F58A8FF4EBQ37154414-5F543F49-A6AF-4476-BD5D-695C32E4C0B7Q37402408-A790C10D-3436-42C8-B32E-411A48FF4522Q37412926-822E2070-DAEE-4A3B-89E1-37D3E038EAD6Q37508046-0A466D61-6F92-45D1-82F3-1EE68C178E76Q37643142-ADE739C5-729B-46EF-93FF-C708ACC73CF7Q37869412-4467BAA1-8D81-43E4-B857-1A0EC1ABDA70Q37998921-FC37AC49-DB90-4EC2-964A-2C74648DE84CQ38015749-9BE8B113-6F23-492B-B992-81959CEE89BCQ38066529-F1A97BDB-9820-43B7-9214-8FF779E838DB
P2860
Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Guidelines for the prevention ...... e Control and Prevention, U.S.
@ast
Guidelines for the prevention ...... e Control and Prevention, U.S.
@en
Guidelines for the prevention ...... e Control and Prevention, U.S.
@nl
type
label
Guidelines for the prevention ...... e Control and Prevention, U.S.
@ast
Guidelines for the prevention ...... e Control and Prevention, U.S.
@en
Guidelines for the prevention ...... e Control and Prevention, U.S.
@nl
prefLabel
Guidelines for the prevention ...... e Control and Prevention, U.S.
@ast
Guidelines for the prevention ...... e Control and Prevention, U.S.
@en
Guidelines for the prevention ...... e Control and Prevention, U.S.
@nl
P2093
P356
P1433
P1476
Guidelines for the prevention ...... e Control and Prevention, U.S.
@en
P2093
Dennis G Maki
E Patchen Dellinger
Henry Masur
Issam I Raad
Julie L Gerberding
Leonard A Mermel
Mary Alexander
Michele L Pearson
Naomi P O'Grady
Rita D McCormick
P356
10.1542/PEDS.110.5.E51
P407
P577
2002-11-01T00:00:00Z